PMC:7283670 / 56355-56462 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T341","span":{"begin":92,"end":100},"obj":"Disease"}],"attributes":[{"id":"A341","pred":"mondo_id","subj":"T341","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) as a treatment for patients with COVID‐19 Drug:"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T541","span":{"begin":12,"end":17},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T542","span":{"begin":62,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) as a treatment for patients with COVID‐19 Drug:"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T38531","span":{"begin":18,"end":29},"obj":"Chemical"}],"attributes":[{"id":"A11733","pred":"chebi_id","subj":"T38531","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) as a treatment for patients with COVID‐19 Drug:"}

{"project":"LitCovid-sentences","denotations":[{"id":"T613","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) as a treatment for patients with COVID‐19 Drug:"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1807","span":{"begin":18,"end":49},"obj":"Gene"},{"id":"1880","span":{"begin":12,"end":17},"obj":"Species"},{"id":"1881","span":{"begin":78,"end":86},"obj":"Species"},{"id":"2097","span":{"begin":92,"end":100},"obj":"Disease"}],"attributes":[{"id":"A1807","pred":"tao:has_database_id","subj":"1807","obj":"Gene:59272"},{"id":"A1880","pred":"tao:has_database_id","subj":"1880","obj":"Tax:9606"},{"id":"A1881","pred":"tao:has_database_id","subj":"1881","obj":"Tax:9606"},{"id":"A2097","pred":"tao:has_database_id","subj":"2097","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Recombinant human angiotensin‐converting enzyme 2 (rhACE2) as a treatment for patients with COVID‐19 Drug:"}